Collection of biological samples from COVID-19 patients
Biological Samples Collection From Patients and Caregivers Treated at Bordeaux University Hospital for Asymptomatic and Symptomatic Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Infection (COVID-19).
University Hospital, Bordeaux · NCT04332016
This study is collecting samples from COVID-19 patients and their caregivers to help researchers learn more about the virus and improve treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | N/A to 100 Years |
| Sex | All |
| Sponsor | University Hospital, Bordeaux (other) |
| Locations | 1 site (Bordeaux) |
| Trial ID | NCT04332016 on ClinicalTrials.gov |
What this trial studies
This study focuses on collecting, processing, and storing biological samples from patients and caregivers infected with the SARS-CoV-2 coronavirus. It aims to support various research projects related to COVID-19 by establishing a comprehensive biobank at the Bordeaux University Hospital. The study includes both symptomatic and asymptomatic individuals, as well as post-mortem samples from patients who have died due to the infection. The collected samples will be utilized for research across multiple disciplines to enhance understanding and treatment of the disease.
Who should consider this trial
Good fit: Ideal candidates include patients and caregivers treated for COVID-19 at Bordeaux University Hospital, including adults, minors, and pregnant or breastfeeding women.
Not a fit: Patients who are under guardianship or curatorship will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly advance research on COVID-19 and improve therapeutic strategies for managing the disease.
How similar studies have performed: Other studies have successfully utilized biological sample collections to advance research on infectious diseases, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients / caregivers treated at Bordeaux University Hospital for asymptomatic or symptomatic infection by SARS -CoV-2 * men and women, adults and minors as well as pregnant or breastfeeding women * patients who died following infection with SARS-CoV-2 (specific criterion for post-mortem biopsies) * Be affiliated with or beneficiary of a social security scheme * Free and informed consent obtained and signed by the patient Exclusion Criteria: * Under guardianship or curatorship
Where this trial is running
Bordeaux
- Centre Hospitalier Universitaire de Bordeaux — Bordeaux, France (RECRUITING)
Study contacts
- Study coordinator: Isabelle PELLEGRIN
- Email: isabelle.pellegrin@chu-bordeaux.fr
- Phone: 05 57 82 11 50
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Infection Viral, COVID-19, SARS-CoV-2, coronavirus, biological samples